A psychedelic drug could find potential beyond mental health, with researchers exploring psilocybin to prevent chemotherapy-related nerve damage.
Nadda pushes advanced diagnostics at Safdarjung Hospital, adding specialized facilities to strengthen affordable patient care and diagnostic capacity.
Ionis wins FDA approval for the first Alexander disease treatment, offering adults and children a new therapy for this rare disorder.
Medicine overpricing in India has triggered a dispute as drug companies challenge the NPPA’s proposal to shift sole accountability onto manufacturers.
The global race to outpace cancer is accelerating, with MedGenome, HUTCHMED, AbbVie and Cipla advancing detection, treatment, survival and access.
VitSupp, a science-first wellness brand that aims to simplify nutrition, has announced the launch of its first product: a clean-label, high-absorption Vegan Vitamin D3 + K2 supplement, specifically created
India could face 16.9 million dementia cases by 2036, making a stronger dementia care ecosystem an urgent priority now.
As swine flu cases climb, Uttar Pradesh moves to make government hospital testing free and strengthens surveillance across the state.
Pharma companies are advancing critical care with innovative drugs, rare-disease research, and preventive diagnostics to address unmet needs.
Swine flu concerns are spreading from Delhi to Agra as Uttar Pradesh steps up surveillance, screening and hospital preparedness to track H1N1 cases.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")